Please login to the form below

Evotec

This page shows the latest Evotec news and features for those working in and with pharma, biotech and healthcare.

Novo Nordisk and Evotec ink drug development deal

Novo Nordisk and Evotec ink drug development deal. Will develop drugs for obesity and diabetes. ... Novo on the other hand, will hone in on Evotec’s INDiGO platform to move the selected candidates through pre-clinical testing.

Latest news

Daily Brief: DeepMind and NHS success in AI eyecare, Bayer invests in COPD, Alecensa OK in Scotland

As part of the collaboration, Bayer receives an exclusive licence to worldwide rights to programmes developed by Haplogen and Evotec. ... Undisclosed upfront payment and potential milestone and royalty-based payments will also be paid by Haplogen to
Sanofi poaches Peugeot's finance head

On top of this, Sanofi is also re-shaping its pipeline after it made a deal to transfer its anti-invectives unit to biotech Evotec.
Evotec says Sanofi deal makes it anti-infectives powerhouse

unit to become an open science focal point – bringing together other “companies, foundations, academia, and government agencies, ”says Evotec. ... That essentially means getting other research groups to put drug candidates through Evotec’s R&D
Daily Brief: Gottlieb sets out cell and gene pathway, NICE says no to Chiesi ultra-rare treatment and more

BIG BIOTECH. Celgene expands drug discovery alliance with Evotec. Celgene is experiencing a rollercoaster 2018, with late-stage drug setbacks, the departure of senior executives, and investor pressure to improve its ... Evotec has built a reputation for
Gottlieb sets out cell and gene pathway, NICE says no to Chiesi ultra-rare treatment and more

BIG BIOTECH. Celgene expands drug discovery alliance with Evotec. Celgene is experiencing a rollercoaster 2018, with late-stage drug setbacks, the departure of senior executives, and investor pressure to improve its ... Evotec has built a reputation for

More from news
Approximately 12 fully matching, plus 27 partially matching documents found.

Latest Intelligence

Pharma deals continue to slide

For example, Evotec, the German small molecule development company, is acquiring for $300m the US preclinical development company, Aptuit. ... 400. Aptuit (US). Evotec (DE). Company acquisition. Drug discovery and development to IND submission including
Deal Watch December 2016

320. Evotec (Germany). Celgene (US). Discovery collaboration. Induced pluripotent stem cells for neurodegenerative diseases. ... upfront. And although the upfronts are a modest percentage of the headline figure, ranging from < 1% (BioInvent) to 15%
Pharma deals in August 2015

Acquisition of Priority Review Voucher. 350. Evotec. Sanofi. Beta cell modulating treatments for diabetes. ... Acquisition ‐ company. 300. Aperion Biologics Evotec. Sanofi. To develops mall molecule immuno‐ therapies.
Deal Watch table for December 2014

Company acquisition. 375. Evotec / Sanofi. R&D alliance to progress Sanofi discovery phase compounds to preclinical stage (inc Sanofi discovery facility with 200 scientists).
Deal Watch table for November 2013

130. Evotec /Janssen. R&D collaboration. Target AD collaboration to identify novel therapies for Alzheimer's.

More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest appointments

Apitope strengthens its board with new director

He has also served on several boards including Ablynx, Evotec and Acambis.
Evotec CEO Werner Lanthaler temporarily stands down

Evotec CEO Werner Lanthaler temporarily stands down. Cites health reasons. Evotec's CEO Dr Werner Lanthaler, has temporarily stood down from his role within the company due to health reasons.

More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Senior Account Manager / Account Director - Medical Education – ...: Salary TBC

Senior Medical Writer: Salary is DOE

Graduate Scientific Editor: DOE

Systematic Review Lead- London: Negotiable

Senior Medical Writer, MedComms Agency: £40 - 55, 000 according to skills and experience benefits

Senior/ Market Access Consultant, UK, HOME BASED, £50-60K: Excellent package

Medical Writer - Creative and Scientific Projects: DOE

Senior Strategist/ Planner, Healthcare Marketing, London: Excellent package

Senior Training Manager - Surrey: Competitive Salary &Bonus

Account Manager- 4 days per week or full-time: Salary TBC

Principal Medical Writer / Editorial Director – Medical Communic...: £60, 000 - £80, 000

Senior Account Manager – Healthcare Advertising: Salary TBC

Digital Account Director – Health/ Pharma – Global Agency: Salary TBC

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Account Director, Healthcare Advertising Agency: Salary TBC

Deputy Managing Director – Healthcare PR – Global Agency: Negotiable

Senior Writer, Healthcare Advertising, London: Excellent package

Account Director or Senior Account Director: Salary TBC

Account Director, Medical Communications & Events: £50 - 65, 000 according to skills and experience benefits

Account Director, Healthcare Communications Agency: £54, 000- £60, 000

Market Access Consultant - Greater Manchester: Negotiable

Science Writer, Healthcare Advertising Agency: £40, 000 - 45, 000 DOE benefits,

Healthcare PR Senior Account Manager: Salary TBC

Head of Market Access - International - Based Cambridge: Excellent Basic, Bonus and Flex Benefits

Healthcare PR Director: £100, 000 – £120, 000 benefits

Subscribe to our email news alerts

PMHub

Add my company

SEVEN STONES

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Latest intelligence

PM Society Digital Awards – the power of together: Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduce anyone in four simple steps: You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government: GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....